XML 35 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2015
Related Party Transactions [Abstract]  
Summary of activities related to related party

 

Milestones Payments 
    
(1) filing of an New Drug Application (“NDA”) or regulatory approval for each licensed product $750,000 
(2) upon the receipt of regulatory approval from the U.S. FDA for each licensed product  1,750,000